Multidrug-resistant Gram-negative bacilli sepsis from a neonatal intensive care unit: a case-case-control study

Anucha Thatrimontrichai1, Nutchana Premprat2, Waricha Janjindamai3

  • 1Division of Neonatology, Department of Pediatrics, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. tanucha@medicine.psu.ac.th.

Abstract

Insights

Multidrug-resistant Gram-negative bacilli (MDRGNB) sepsis in neonates is linked to adverse outcomes and increased costs. Interventions to reduce MDRGNB sepsis in neonatal intensive care units (NICUs) are cost-effective.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • Neonatal sepsis remains a significant cause of morbidity and mortality worldwide.
  • Multidrug-resistant Gram-negative bacilli (MDRGNB) pose a growing threat in neonatal intensive care units (NICUs).
  • Understanding the specific risks and outcomes associated with MDRGNB sepsis is crucial for effective management.

Purpose of the Study:

  • To identify risk factors and clinical outcomes for neonates with multidrug-resistant Gram-negative bacilli (MDRGNB) sepsis.
  • To compare these risks and outcomes against non-MDRGNB sepsis and a control group without culture-proven sepsis.

Main Methods:

  • Retrospective case-case-control study conducted between 1991 and 2016.
  • Inclusion of three groups: MDRGNB sepsis, non-MDRGNB sepsis, and a control group (suspected sepsis without culture confirmation).
  • Statistical analysis using adjusted odds ratios (aOR) to determine significant associations.

Main Results:

  • MDRGNB sepsis was associated with outborn infants, neurologic sequelae, lower gestational age, and prior aminoglycoside use.
  • Non-MDRGNB sepsis was linked to outborn infants, neurologic sequelae, and prior cephalosporin or cefoperazone/sulbactam use.
  • Higher case fatality rates, septic shock, longer hospital stays, and increased daily costs were observed in the MDRGNB sepsis group compared to controls.

Conclusions:

  • Smaller preterm neonates with prior aminoglycoside exposure are at higher risk for MDRGNB sepsis.
  • Interventions aimed at reducing MDRGNB sepsis in the NICU setting are likely to be cost-effective.
  • The findings underscore the importance of targeted prevention and management strategies for MDRGNB infections in neonates.